Drugs Made In America Acquisition Corp. (DMAA) stock
DMAANasdaqBlank ChecksFiscal year ends December 31Also trades as DMAAR, DMAAU
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.90+0.00 (0.00%)
Close on Nov 16, 2026Market cap $264.62MP/E –Yield –
Drugs Made In America Acquisition enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Drugs Made In America Acquisition's enterprise value was $116.80M on Nov 11, 2026, against $108.64M a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $116.80M | +7.0% |
| 2025 | Dec 31, 2025 | $109.11M | – |
See a number that looks wrong?